Trademark: 97198644
Word
R
Status
Registered
Status Code
700
Status Date
Tuesday, January 24, 2023
Serial Number
97198644
Registration Number
6963961
Registration Date
Tuesday, January 24, 2023
Mark Type
5000
Filing Date
Friday, December 31, 2021
Published for Opposition
Tuesday, November 8, 2022

Trademark Owner History
Revir Therapeutics, Inc. - Original Registrant

Classifications
42 Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Medical and scientific research in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, bacteriology, medical diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; Scientific research and development; Scientific research and development of diagnostic methods and test processes; Scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; Scientific consultancy services in the field of research and development of therapies and medical preparations; Provision of scientific expertise in the nature of scientific study and research in the field of medicine; Scientific research and development for medical and veterinary purposes; Medical and scientific research in the field of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease, metabolic diseases; Providing medical and scientific research information, consultancy, and advisory services in the fields of treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, and neurodegenerative disease; Compiling data for medical and scientific research, clinical trials, and drug admission
The mark consists of a stylized letter "R" sharing a stroke "|" with a stylized upside-down inverted "R", where the stylized letter "R" has two openings between the stroke "|" and the right part of "R" and the stylized upside-down inverted "R" has two openings between the stroke "|" and the left part of the upside-down inverted "R".
R R
RR
REVIR
Color is not claimed as a feature of the mark.

Trademark Events
Jan 24, 2023
Notice Of Registration Confirmation Emailed
Jan 24, 2023
Registered-Principal Register
Nov 8, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 8, 2022
Published For Opposition
Oct 19, 2022
Notification Of Notice Of Publication E-Mailed
Oct 5, 2022
Approved For Pub - Principal Register
Oct 5, 2022
Examiner's Amendment Entered
Oct 5, 2022
Notification Of Examiners Amendment E-Mailed
Oct 5, 2022
Examiners Amendment E-Mailed
Oct 5, 2022
Examiners Amendment -Written
Oct 4, 2022
Assigned To Examiner
Sep 1, 2022
Teas Change Of Correspondence Received
Sep 1, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 1, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 1, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 5, 2022
New Application Office Supplied Data Entered
Jan 4, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24